These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2189591)
1. Intrapleural etoposide for malignant effusion. Holoye PY; Jeffries DG; Dhingra HM; Holmes FA; Raber M; Engineer MS; Newman RA Cancer Chemother Pharmacol; 1990; 26(2):147-50. PubMed ID: 2189591 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion. Montaldo PG; Figoli F; Zanette ML; Sorio R; Zucchetti M; Tirelli U; D'Incalci M Oncology; 1990; 47(1):55-61. PubMed ID: 2300386 [TBL] [Abstract][Full Text] [Related]
3. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions. Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613 [TBL] [Abstract][Full Text] [Related]
5. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694 [TBL] [Abstract][Full Text] [Related]
6. Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion. Lerza R; Vannozzi MO; Tolino G; Viale M; Bottino GB; Bogliolo G; Cerruti A; Castello G; Mencoboni M; Reggiardo G; Pannacciulli I; Esposito M Ann Oncol; 1997 Apr; 8(4):385-91. PubMed ID: 9209670 [TBL] [Abstract][Full Text] [Related]
7. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study. Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232 [TBL] [Abstract][Full Text] [Related]
8. Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. Bennett CL; Sinkule JA; Schilsky RL; Senekjian E; Choi KE Cancer Res; 1987 Apr; 47(7):1952-6. PubMed ID: 3815383 [TBL] [Abstract][Full Text] [Related]
9. [Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion]. Kitajima K; Fukuoka M; Kusunoki Y; Negoro S; Takada M; Matsui K; Sakai N; Ryu S; Takifuji N; Masuda N Gan To Kagaku Ryoho; 1988 Dec; 15(12):3253-9. PubMed ID: 3196043 [TBL] [Abstract][Full Text] [Related]
10. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364 [TBL] [Abstract][Full Text] [Related]
11. Intrapleural nivolumab in cancer patients with pleural effusion. Tsimafeyeu I; Goutnik V; Shrainer I; Kosyrev V; Bondarenko A; Utyashev I J Cancer Res Ther; 2024 Apr; 20(3):1036-1038. PubMed ID: 39023613 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of local administration of ACNU in the treatment of malignant pleural effusion]. Honma T; Yoneda S; Yoshida S; Komuro Y; Takayama S Gan To Kagaku Ryoho; 1982 Feb; 9(2):316-22. PubMed ID: 6964036 [TBL] [Abstract][Full Text] [Related]
13. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis. Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881 [TBL] [Abstract][Full Text] [Related]
14. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Henke CA; Leatherman JW Am Rev Respir Dis; 1992 Mar; 145(3):680-4. PubMed ID: 1546851 [TBL] [Abstract][Full Text] [Related]
15. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses. Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion. Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393 [TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of low pleural fluid glucose in acidotic malignant pleural effusions. Limthongkul S J Med Assoc Thai; 1989 Sep; 72(9):492-7. PubMed ID: 2809454 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of aquaporin-1 on the pleura of rats with a tuberculous pleural effusion. Du H; Xie C; He Q; Deng X Lung; 2007 Dec; 185(6):325-36. PubMed ID: 17876668 [TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion. Chatzika K; Manika K; Kontou P; Pitsiou G; Papakosta D; Zarogoulidis K; Kioumis I Antimicrob Agents Chemother; 2014; 58(3):1315-9. PubMed ID: 24323477 [TBL] [Abstract][Full Text] [Related]
20. Intrapleural alteplase in a patient with complicated pleural effusion. Walker CA; Shirk MB; Tschampel MM; Visconti JA Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]